Education
About Us
Working with TipRanks
Follow Us
Sandra Leung Insider Profile
4 Followers
Sandra Leung, EVP & GC at Bristol-Myers Squibb, holds 33.82K shares in Bausch Health Companies (Ticker: BHC), holds 465.37K shares in Bristol-Myers Squibb (Ticker: BMY), holds 1.50K shares in Mead Johnson (Ticker: MJN).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-2.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sandra Leung holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 07, 2022 - Jun 07, 2023
Return:+12.20%
The most profitable trade made by Sandra Leung
Sandra Leung's Trading History
Bristol-Myers Squibb
Mar 12, 2025
EVP & GC
Uninformative Buy
1.96M
$20.78M
Bausch Health Companies
Oct 02, 2025
Director
Uninformative Buy
―
$216.12K
Mead Johnson
Feb 17, 2009
―
Informative Buy
36.00K
$134.97K
List of latest transactions for each holding click on a transaction to see Sandra Leung's performance on stock
You May Also Like
Sandra Leung insider profile FAQ
What is the percentage of profitable transactions made by Sandra Leung?
The percentage of profitable transactions made by Sandra Leung is 25%.
What is the average return per transaction made by Sandra Leung?
The average return per transaction made by Sandra Leung is -2.30%.
What stocks does Sandra Leung hold?
Sandra Leung holds: BMY, BHC, MJN stocks.
What was Sandra Leung’s latest transaction?
Sandra Leung latest transaction was an Uninformative Buy of ―.
What was Sandra Leung's most profitable transaction?
Sandra Leung’s most profitable transaction was an Informative Sell of BMY stock on June 7, 2022. The return on the trade was 12.20%.
What is Sandra Leung's role in Bristol-Myers Squibb?
Sandra Leung's role in Bristol-Myers Squibb is EVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.